openPR Logo
Press release

Antinuclear Antibody Test Market Outlook 2021 Witnessing Enormous Growth with Recent Trends & Demand | Alere Inc., Bio-Rad Laboratories, ZEUS Scientific

06-08-2021 07:09 PM CET | Health & Medicine

Press release from: Brandessence Market Research & Consulting Pvt ltd.

Antinuclear Antibody Test Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Antinuclear Antibody Test Market place for the forecast 2020– 2025.

On the basis of estimation, the occurrence rate of lupus is 16,000 new cases annually. Lupus impacts mostly females of childbearing age. On the other hand, teenagers, children, and men get lupus too. Most of the individuals having lupus get the disease between 15–44 years of age. As per Arthritis Foundation, almost 1 in 3 individuals aged between 18–64 years suffer from arthritis. The number of people in the US with doctor-detected arthritis is predicted to increase by 49% by 2040.

Get Sample of This Report:@https://brandessenceresearch.com/requestSample/PostId/765?utm_source=op&utm_medium=Djay

Scope of The Report:
Antinuclear antibodies are a bunch of autoantibodies created by a person’s immune system when it fails to differentiate between foreign and self particles. ANA (Antinuclear antibody) is also dibbed as FANA (fluorescent antinuclear antibody) and antinuclear antibody screen. Antinuclear antibodies attack the own body cells. Thus, these are dubbed as antinuclear, as these cells target the cells’ nucleus. Antinuclear antibodies react with elements of the body’s own fit cells and lead to signs and symptoms such as muscle & joint pain, organ & tissue inflammation, and fatigue. Antinuclear antibodies test identifies autoantibodies in the blood. An antinuclear antibodies test decides the attendance of antinuclear antibodies in the blood. If a test identifies antinuclear antibodies in an individual’s body, it can mean that the individual has an autoimmune disorder. An antinuclear antibodies test is employed to assist diagnose autoimmune disorders, comprising scleroderma, rheumatoid arthritis, systemic lupus erythematosus, and Sjogren's syndrome.

Antinuclear Antibody Test Companies:
The major players included in the global antinuclear antibody test market forecast are,

Alere, Inc.
Bio-Rad Laboratories
ZEUS Scientific
Antibodies, Inc.
Immuno Concepts
Erba Diagnostics
Trinity Biotech plc
Inova Diagnostics
Euroimmun AG.

Antinuclear Antibody Test Market Key Segments:
By Product: Reagents & Assay Kits, Systems, Software & Services

By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjgrens Syndrome, Scleroderma, Other Diseases

By Technique: ELISA, Immunofluorescence Assay, Multiplex Assay

Market by Regional Analysis

North America (USA, Canada, Mexico), Europe (UK, France, Germany, Russia, Rest of Europe), Asia-Pacific (China, South Korea, India, Japan, Rest of Asia-Pacific), LAMEA, Latin America, Middle East, Africa

Increase In Occurrence Of Autoimmune Disorders To Power The Development Of The Global Antinuclear Antibody Test Market

The global antinuclear antibody test market is expected to develop at a quick speed during the coming period. Increase in occurrence of autoimmune disorders such as systemic lupus erythematosus and rheumatoid arthritis and rise in acceptance of antinuclear antibodies tests are the primary factors expected to power the global market during the coming period. As per the Lupus Foundation of America, almost 5 million individuals all over the world and an expected 1.5 million individuals in the US are having lupus.

Full Research Report:@https://brandessenceresearch.com/healthcare/antinuclear-antibody-test-market-size

Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com
Website: https://brandessenceresearch.com/

About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antinuclear Antibody Test Market Outlook 2021 Witnessing Enormous Growth with Recent Trends & Demand | Alere Inc., Bio-Rad Laboratories, ZEUS Scientific here

News-ID: 2300920 • Views:

More Releases from Brandessence Market Research & Consulting Pvt ltd.

Neuroscience Antibodies and Assays Market Scenario, Gross Margin, Future Trends, …
Market Overview: Global Neuroscience Antibodies and Assays Market to reach USD 5.1 billion by 2025 Global Neuroscience Antibodies and Assays Market valued approximately USD 2.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 10.3% over the forecast period 2017-2025. The increasing automation of high-throughput screening and the availability of robust data management software tools, which enable researchers to develop systemic and process-oriented approaches toward neuroscience
Atomic Layer Deposition (ALD) Market Revenue, Top Players, Impact Analysis, Upco …
Market Overview: Global Atomic Layer Deposition (ALD) Market to reach USD 3.1 billion by 2025 Global Atomic Layer Deposition (ALD) Market valued approximately USD 1.1 billion in 2016 is anticipated to grow with a healthy growth rate of more than 12.04% over the forecast period 2017-2025. Increasing need for miniaturized components and Nano-technology, advancement in electronic sectors, increasing concern for global warming and emergence of new technologies like dye-sensitized solar cells, are
Diabetic Neuropathy Market Share, Company Profiles, Future Demand, Opportunities …
Market Overview: Global Diabetic Neuropathy Market to reach USD 8460.3 million by 2025. Global Diabetic Neuropathy Market valued approximately USD 4680 million in 2016 is anticipated to grow with a healthy growth rate of more than 6.80% over the forecast period 2017-2025. The growth of this market primarily driven by the ever-growing pool of geriatric population with diabetes. The rise in availability of suitable treatment options and the growing awareness on PDN
Circulating Tumor Cells (CTC) Market Global Trends, COVID-19 Impact Analysis, Co …
Market Overview: Global Circulating Tumor Cells (CTC) Market to reach USD 22.5 billion by 2025 Global Circulating Tumor Cells (CTC) Market valued approximately USD 5 billion in 2016 is anticipated to grow with a healthy growth rate of more than 18.20% over the forecast period 2017-2025. Circulating tumor cells are significantly useful in determining the status of disease progression rate and projection of therapy needed for tumor eradication. Further development of various

All 5 Releases


More Releases for Antinuclear

Antinuclear Antibody Test Market Size - Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Antinuclear Antibody Test Market is projected to grow from USD 1.50 billion in 2021 to USD 2.74 billion by 2026 at a CAGR value of 12.8% from 2021 to 2026. The market is expected to be driven by the increasing prevalence of autoimmune illnesses, as well as rising awareness amongst patients and healthcare providers regarding these
Antinuclear Antibody Test Market Report Up to 2031
Visiongain has published a new report on Antinuclear Antibody Test Market Report to 2031. Market is segmented by product/services (reagents & assay kits, system, software & services), by application (rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome, scleroderma, other), by techniques (ELISA, immunofluorescence assay, multiplex assay, others), by end user (hospitals, clinical laboratories, others). By region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed
Antinuclear Antibody Testing Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Antinuclear Antibody Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Antinuclear Antibody Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Global Antinuclear Antibody Test Market Research and Forecast 2018-2023
Global Antinuclear Antibody Test Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023 Antinuclear antibody test market are unusual antibodies such as bacteria and viruses that attack the healthy proteins of the cell. These are primarily found in patients whose immune system causes inflammation against its own body tissues. The antinuclear antibody test is used to evaluate for autoimmune diseases that can affect the tissues and organs
Antinuclear Antibody Test Market Predicted to Witness Steady Growth
Antinuclear antibody test is a sensitive screening test used to diagnose autoimmune disorders. The test is used in symptoms such as low-grade fever, skin sensitivity to light, persistent fatigue, weakness and inflammation, and damage to organs and tissues. The test gives two types of results: positive result and negative result. A positive test indicates the presence of autoantibody. Enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody (IFA) are the two
Antinuclear Antibody Test Market to Witness an Outstanding Growth by 2024
Antinuclear antibody test is a sensitive screening test used to diagnose autoimmune disorders. The test is used in symptoms such as low-grade fever, skin sensitivity to light, persistent fatigue, weakness and inflammation, and damage to organs and tissues. The test gives two types of results: positive result and negative result. A positive test indicates the presence of autoantibody. Enzyme-linked immunosorbent assay (ELISA) and indirect fluorescent antibody (IFA) are the two